Jushi Holdings (JUSHF) Profit After Tax (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Profit After Tax of -$7.3 million for Q2 2026, up 40.56% year-over-year from -$5.2 million in Q2 2025, and up 63.07% quarter-over-quarter from -$19.8 million in Q1 2026.
Jushi Holdings (JUSHF) Profit After Tax (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Profit After Tax for 6 consecutive years, with -$7.3 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Profit After Tax rose 40.56% year-over-year to -$7.3 million; the TTM figure through Jun 2026 stood at -$66.4 million (down 14.86% YoY), while the FY2025 annual figure was -$68.6 million, down 40.62% from the prior year.
- Profit After Tax rose to -$7.3 million in Q2 2026 per JUSHF's latest filing, from -$19.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $12.1 million in Q2 2022 and bottomed at -$139.9 million in Q4 2022.
- Historically, Profit After Tax has averaged -$22.9 million across 5 years, with a median of -$16.5 million in 2024.
- On a YoY basis, Profit After Tax climbed as much as 357.74% in 2022 and fell as far as 1735.54% in 2022.
- Jushi Holdings' Profit After Tax stood at -$139.9 million in 2022, then soared by 87.13% to -$18.0 million in 2023, then soared by 30.75% to -$12.5 million in 2024, then declined by 24.77% to -$15.6 million in 2025, then jumped by 52.89% to -$7.3 million in 2026.
- Business Quant data shows JUSHF's Profit After Tax at -$7.3 million in Q2 2026, -$19.8 million in Q1 2026, and -$15.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | -7.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -7.33 Mn |
| Mar 31, 2026 | -19.85 Mn |
| Dec 31, 2025 | -15.56 Mn |
| Sep 30, 2025 | -23.69 Mn |
| Jun 30, 2025 | -12.33 Mn |
| Mar 31, 2025 | -17.02 Mn |
| Dec 31, 2024 | -12.47 Mn |
| Sep 30, 2024 | -16.02 Mn |
| Jun 30, 2024 | -1.94 Mn |
| Mar 31, 2024 | -18.36 Mn |
| Dec 31, 2023 | -18.00 Mn |
| Sep 30, 2023 | -20.62 Mn |
| Jun 30, 2023 | -14.04 Mn |
| Mar 31, 2023 | -12.44 Mn |
| Dec 31, 2022 | -139.94 Mn |
| Sep 30, 2022 | -54.70 Mn |
| Jun 30, 2022 | 12.07 Mn |
| Mar 31, 2022 | -19.76 Mn |
| Dec 31, 2021 | 8.56 Mn |
| Sep 30, 2021 | 39.74 Mn |